Our findings for COL4A1 are also supported by recent reports demonstrating that its depletion impairs proliferation and invasion in hepatocellular carcinoma and glioma cells [84, 85], although its specific role in STAD had not been well characterized prior to this study. This evidence concerns the gene COL4A1 and central nervous system cancer.